Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 15:857:172429.
doi: 10.1016/j.ejphar.2019.172429. Epub 2019 Jun 3.

Interventions to chronic prostatitis/Chronic pelvic pain syndrome treatment. Where are we standing and what's next?

Madanraj Appiya Santharam  1 , Farhan Ullah Khan  2 , Muhammad Naveed  3 , Usman Ali  4 , Muhammad Zaeem Ahsan  4 , Puregmaa Khongorzul  5 , Rana Muhammad Shoaib  4 , Awais Ullah Ihsan  6
Affiliations
Review

Interventions to chronic prostatitis/Chronic pelvic pain syndrome treatment. Where are we standing and what's next?

Madanraj Appiya Santharam et al. Eur J Pharmacol. .

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a frustrating syndrome. The pathogenesis and state of the art treatment of CP/CPPS are not known. A wide variety of therapies including anti-inflammatories, antibiotics, alpha-blockers, neuropathic pain modulators, and 5α-reductase inhibitors are in practice. These treatment strategies focus on alleviating symptoms in specific domains without treating root-cause and therapeutic outcome is far from satisfactory. We review the literature on current pharmacological treatments for CP/CPPS in detail and suggest future perspectives to modify the treatment strategies. We suggest that introducing novel treatment strategies such as gene editing, and Tregs expressing chimeric receptors may improve the treatment outcomes by inducing immune tolerance and controlling expression of pro-inflammatory cytokines.

Keywords: Chronic prostatitis/Chronic pelvic pain syndrome; Diagnosis; Etiology; Future CP/CPPS therapies; Treatment.

PubMed Disclaimer